Plasma assay for the antineoplastic agent VP 16-213 (etoposide) using high-performance liquid chromatography with electrochemical detection
- 31 December 1983
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 1 (1) , 89-97
- https://doi.org/10.1016/0731-7085(83)80012-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In vitro and in vivo metabolism of VP 16–213 in the ratEuropean Journal of Cancer and Clinical Oncology, 1982
- A sensitive high-performance liquid chromatographic method for determination of the anti-neoplastic agents vp 16-213 and vm 26 in biological fluidsAnalytica Chimica Acta, 1981
- Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Comparison of several voltammetric detectors for high-performance liquid chromatographyJournal of Chromatography A, 1981
- High-performance liquid chromatography determination of 4′-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene β-d-glucopyranoside) (VP 16-213) in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Analysis of 4′-demethylepipodophyllotoxin-9-(4,6-o-ethylidene-β-d-glucopyranoside) by high-pressure liquid chromatographyJournal of Pharmaceutical Sciences, 1980
- Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- VM 26 and VP 16–213: A comparative analysisCancer, 1977
- Limiting diffusion currents in hydrodynamic voltammetryJournal of Electroanalytical Chemistry and Interfacial Electrochemistry, 1973
- Mitosis-inhibiting natural products. 24. Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxinJournal of Medicinal Chemistry, 1971